Protected: The VESL Wall Issue #4 is now out! This month, we cover practical ASCVD risk reduction in the South Asian population, dive into the apoB debate, and evaluate lipid testing and therapy post-ACS in the Alberta population.

This content is password protected. To view it please enter your password below: